RU2019121145A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2019121145A3 RU2019121145A3 RU2019121145A RU2019121145A RU2019121145A3 RU 2019121145 A3 RU2019121145 A3 RU 2019121145A3 RU 2019121145 A RU2019121145 A RU 2019121145A RU 2019121145 A RU2019121145 A RU 2019121145A RU 2019121145 A3 RU2019121145 A3 RU 2019121145A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1700542.2A GB201700542D0 (en) | 2017-01-12 | 2017-01-12 | Probiotic compositions and uses thereof |
| GB1700542.2 | 2017-01-12 | ||
| GB1709731.2 | 2017-06-19 | ||
| GBGB1709731.2A GB201709731D0 (en) | 2017-06-19 | 2017-06-19 | Probiotic compositions and uses thereof |
| PCT/EP2018/050789 WO2018130667A1 (en) | 2017-01-12 | 2018-01-12 | Probiotic compositions and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2019121145A RU2019121145A (ru) | 2021-02-12 |
| RU2019121145A3 true RU2019121145A3 (https=) | 2021-04-26 |
| RU2763311C2 RU2763311C2 (ru) | 2021-12-28 |
Family
ID=61386800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019121145A RU2763311C2 (ru) | 2017-01-12 | 2018-01-12 | Пробиотические композиции и их применение |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11166993B2 (https=) |
| EP (1) | EP3568144B1 (https=) |
| JP (1) | JP7089523B2 (https=) |
| KR (1) | KR102500496B1 (https=) |
| CN (1) | CN110177561B (https=) |
| AU (1) | AU2018207946B2 (https=) |
| BR (1) | BR112019014418A2 (https=) |
| CA (1) | CA3049624A1 (https=) |
| CL (1) | CL2019001938A1 (https=) |
| MX (1) | MX2019008292A (https=) |
| MY (1) | MY195253A (https=) |
| PH (1) | PH12019501629A1 (https=) |
| RU (1) | RU2763311C2 (https=) |
| WO (1) | WO2018130667A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019289515B2 (en) * | 2018-06-18 | 2025-07-24 | Probi Ab | Probiotic compositions and uses thereof |
| IT201900014550A1 (it) * | 2019-08-09 | 2021-02-09 | Abiogen Pharma Spa | Uso di colecalciferolo come agente attivo nel trattamento della celiachia |
| CN116869141A (zh) * | 2022-05-05 | 2023-10-13 | 内蒙古一康健康发展有限责任公司 | 一种具有保健功能的益生菌复合物及其制备方法 |
| KR102845919B1 (ko) * | 2023-02-28 | 2025-08-14 | 주식회사 피엘비앤비 | 장내 유해세균의 성장 억제 성능이 우수한 한국인 모유 유래 락티카제이바실러스 파라카제이 pl1536 및 이를 유효성분으로 포함하는 기능성식품 조성물 |
| CN119279210A (zh) * | 2024-12-16 | 2025-01-10 | 山东健源生物科技有限公司 | 一种复合益生菌发酵含药食同源物质的多谷物后生元制剂及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004076615A2 (en) * | 2003-02-27 | 2004-09-10 | Bioneer A/S | Immunomodulating probiotic compounds |
| WO2006097949A1 (en) * | 2005-03-16 | 2006-09-21 | Actial Farmacêutica, Lda. | Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough |
| WO2007040446A1 (en) * | 2005-10-06 | 2007-04-12 | Probi Ab | Use of lactobacillus for treatment of autoimmune diseases |
| CN101325960B (zh) * | 2005-10-06 | 2012-05-30 | 普罗比公司 | 乳酸杆菌用于治疗自身免疫性疾病的用途 |
| WO2007108763A1 (en) * | 2006-03-17 | 2007-09-27 | Probac Ab | Use of lactobacillus strains for promoting immunotolerance in autoimmune disease |
| PT1996696T (pt) | 2006-03-17 | 2017-03-17 | Probi Ab | Estirpes de lactobacillus termoestáveis |
| HUE027237T2 (en) * | 2008-11-30 | 2016-10-28 | Immusant Inc | Compositions and methods for treatment of celiac disease |
| EP2581461B1 (en) * | 2011-10-14 | 2014-09-24 | GenMont Biotech Incorporation | Composition and use of lactobacillus paracasei strain GMNL-133 in treating atopic dermatitis or other allergic diseases |
| EP3351554B1 (en) | 2012-06-18 | 2021-06-09 | H.J. Heinz Company Brands LLC | Gluten-related disorders |
| JP6103675B2 (ja) * | 2013-04-03 | 2017-03-29 | プロビ アーベ | 骨粗鬆症の治療または予防に使用するプロバイオティクス菌株 |
| CN108064158B (zh) * | 2014-11-25 | 2021-12-21 | 帝斯曼知识产权资产管理有限公司 | 用作益生菌的Lactobillus和用于评估对试剂如益生菌的免疫应答的血细胞群 |
-
2018
- 2018-01-12 EP EP18707627.8A patent/EP3568144B1/en active Active
- 2018-01-12 BR BR112019014418-8A patent/BR112019014418A2/pt active Search and Examination
- 2018-01-12 CA CA3049624A patent/CA3049624A1/en active Pending
- 2018-01-12 RU RU2019121145A patent/RU2763311C2/ru active
- 2018-01-12 CN CN201880006818.0A patent/CN110177561B/zh active Active
- 2018-01-12 MX MX2019008292A patent/MX2019008292A/es unknown
- 2018-01-12 US US16/477,259 patent/US11166993B2/en active Active
- 2018-01-12 MY MYPI2019003890A patent/MY195253A/en unknown
- 2018-01-12 KR KR1020197022803A patent/KR102500496B1/ko active Active
- 2018-01-12 AU AU2018207946A patent/AU2018207946B2/en active Active
- 2018-01-12 JP JP2019538207A patent/JP7089523B2/ja active Active
- 2018-01-12 WO PCT/EP2018/050789 patent/WO2018130667A1/en not_active Ceased
-
2019
- 2019-07-11 CL CL2019001938A patent/CL2019001938A1/es unknown
- 2019-07-12 PH PH12019501629A patent/PH12019501629A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3568144A1 (en) | 2019-11-20 |
| WO2018130667A1 (en) | 2018-07-19 |
| EP3568144C0 (en) | 2024-05-08 |
| RU2019121145A (ru) | 2021-02-12 |
| JP7089523B2 (ja) | 2022-06-22 |
| AU2018207946B2 (en) | 2024-07-18 |
| KR102500496B1 (ko) | 2023-02-16 |
| EP3568144B1 (en) | 2024-05-08 |
| US20190358275A1 (en) | 2019-11-28 |
| MY195253A (en) | 2023-01-11 |
| KR20190104568A (ko) | 2019-09-10 |
| CN110177561A (zh) | 2019-08-27 |
| RU2763311C2 (ru) | 2021-12-28 |
| AU2018207946A1 (en) | 2019-07-25 |
| JP2020513780A (ja) | 2020-05-21 |
| MX2019008292A (es) | 2019-09-16 |
| CN110177561B (zh) | 2023-09-12 |
| BR112019014418A2 (pt) | 2020-04-14 |
| CA3049624A1 (en) | 2018-07-19 |
| US11166993B2 (en) | 2021-11-09 |
| PH12019501629A1 (en) | 2020-06-01 |
| CL2019001938A1 (es) | 2019-09-27 |